Sanofi Viscosupplement Growth in Emerging Markets Offsets U.S. Losses
Sanofi’s 3Q19 viscosupplement sales growth in emerging markets and offset declines in the U.S., marking the first quarter of Synvisc growth in 2019. Nov 05, 2019
Strength in Knee Replacement and Sports Medicine Drives Smith+Nephew Growth
Smith+Nephew's 3Q19 growth was powered by strength in knee replacement and sports medicine, as well as contributions from recently acquired Osiris. Nov 04, 2019
Stryker Acquires Wright Medical, Speeds Path to Leadership in Extremities
Stryker acquires Wright Medical for $30.75 per share, total equity value of $4 billion. Nov 04, 2019
U.S. Spinal Hardware Sales Continues to Drive NuVasive Growth
NuVasive’s 3Q19 growth was driven by sales of U.S. spinal hardware as the company continues to evangelize adoption of minimally invasive spinal surgery. Nov 01, 2019
ConMed Grows Above Market on Leadership Continuity and New Products
ConMed’s sports medicine business grew in the high single digits in 3Q19, driven by continuity of its leadership team and new product introductions. Nov 01, 2019
Alphatec Spine Continues Success Story with New Product Launches and a Revitalized Sales Channel
Alphatec continued its run of double-digit growth in 3Q19 on the strength of an aggressive new product launch schedule and a revitalized sales channel. Nov 01, 2019
Spinal Implant Growth Drives SeaSpine to Record Revenues
SeaSpine recorded the highest revenue in company history in 3Q19, driven by the Shoreline and Mariner implant systems as well as OsteoStrand Plus DBM. Oct 31, 2019
Stryker Continues to Outpace Competitors with Solid Execution Across Segments
Except for some challenges with the K2M integration, Stryker once again executed at a high level across all segments in 3Q19. Oct 30, 2019
Orthofix Weighed Down by Management Vacancies and Order Delays
Biologics and the M-6 cervical disc sales were bright spots, but Orthofix faced a “perfect storm” of challenges in 3Q19 that will carry through to 2020. Oct 29, 2019
Episurf Continues to Gather Clinical Evidence During Early Commercialization Efforts
Episurf continued to focus on gathering clinical evidence during its early commercialization efforts in 3Q19. Sales grew 13.4% on orders from Germany. Oct 28, 2019
